| Literature DB >> 26135303 |
Correction: Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients.
Giuseppina Rosaria Rita Ricciardi, Barbara Adamo, Antonio Ieni, Luana Licata, Roberta Cardia, Giuseppa Ferraro, Tindara Franchina, Giovanni Tuccari, Vincenzo Adamo.
Abstract
Entities:
Year: 2015 PMID： 26135303 PMCID： PMC4489771 DOI： 10.1371/journal.pone.0132647
Source DB: PubMed Journal: PLoS One ISSN： 1932-6203 Impact factor: 3.240
×
No keyword cloud information.
Fig 1The E-cadherin, Ki-67 and AR expression in 45 patients TNBC.
Legend: [A, B] E-cadherin negative/positive staining; [C,D] Ki-67 level < or ≥ 20%; [E,F] negative/positive AR staining.
The E-cadherin, Ki-67 and AR expression in 45 patients TNBC.
1 in total
1. Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients.
Journal: PLoS One Date: 2015-06-03 Impact factor: 3.240
1 in total
3 in total
1. Expression of E cadherin and Ki 67: Emerging Prognostic Markers in Triple-Negative Breast Cancer.
Journal: Indian J Surg Oncol Date: 2019-02-07
2. Immunoexpression of lactoferrin in triple-negative breast cancer patients: A proposal to select a less aggressive subgroup.
Journal: Oncol Lett Date: 2017-03-14 Impact factor: 2.967
3. Hispidulin modulates epithelial-mesenchymal transition in breast cancer cells.
Journal: Oncol Lett Date: 2020-12-31 Impact factor: 2.967
3 in total